DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 53 filers reported holding DESIGN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,164,963 | -0.3% | 502,375 | -8.7% | 0.00% | 0.0% |
| Q1 2023 | $3,175,416 | -58.3% | 550,332 | -25.9% | 0.00% | -50.0% |
| Q4 2022 | $7,620,512 | -52.0% | 742,740 | -21.7% | 0.00% | -33.3% |
| Q3 2022 | $15,863,000 | +7.0% | 948,773 | -10.4% | 0.00% | 0.0% |
| Q2 2022 | $14,821,000 | -8.2% | 1,058,649 | +6.0% | 0.00% | 0.0% |
| Q1 2022 | $16,137,000 | -11.9% | 999,173 | +16.8% | 0.00% | 0.0% |
| Q4 2021 | $18,317,000 | +30.5% | 855,538 | -10.5% | 0.00% | +50.0% |
| Q3 2021 | $14,037,000 | -24.0% | 955,588 | +1.7% | 0.00% | -33.3% |
| Q2 2021 | $18,472,000 | -44.8% | 939,362 | -17.7% | 0.00% | -50.0% |
| Q1 2021 | $33,478,000 | – | 1,141,985 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $66,961,644 | 24.44% |
| Cormorant Asset Management, LP | 5,150,000 | $52,839 | 3.54% |
| Logos Global Management LP | 2,797,501 | $28,702,360 | 3.36% |
| RA Capital Management | 2,971,231 | $30,484,830 | 0.62% |
| Ghost Tree Capital, LLC | 82,853 | $850,000 | 0.36% |
| Avoro Capital Advisors LLC | 2,272,222 | $23,312,998 | 0.35% |
| EcoR1 Capital, LLC | 884,903 | $9,079,105 | 0.28% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 57,025 | $585,077 | 0.17% |
| Ikarian Capital, LLC | 48,500 | $497,610 | 0.12% |
| Rock Springs Capital Management LP | 460,391 | $4,723,612 | 0.11% |